Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (SARs activity) (Details)

v3.3.1.900
Stock-Based Compensation (SARs activity) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock or Unit Option Plan Expense   $ 823 $ 727
Restricted Stock or Unit Expense   2,940 1,299
Stock-based compensation   $ 4,017 $ 2,124
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]      
Oustanding, Shares at beginning of the period   1,692,921  
Granted, Shares   24,575  
Exercised, Shares   0  
Forfeited or expired, shares   (690,581)  
Oustanding, Shares at end of the period 1,692,921 1,026,915 1,692,921
Outstanding, Average Grant Price $ 5.12 $ 4.67 $ 5.12
Granted, Average Grant Price   1.33  
Exercised, Average Grant Price   0.00  
Forfeited or expired, Average Grant Price   $ 5.65  
Outstanding, Remaining Contractual Period   2 years 8 months 27 days 3 years 4 months 24 days
Granted, Remaining Contractual Period   2 years 8 months 23 days  
Outstanding, Aggregate Intrinsic Value $ 4 $ 0 $ 4
Granted, Aggregate Intrinsic Value   $ 0  
Exercisable, Shares   1,026,915  
Exercisable, Average Grant Price   $ 4.67  
Exercised, Remaining Contractual Period   2 years 8 months 27 days  
Exercisable, Aggregate Intrinsic Value   $ 0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Nonvested at beginning of the year, Shares   711,003  
Vested, Shares   0  
Nonvested at end of the year, Shares 711,003 0 711,003
Nonvested, Weighted-Average Grant Date Fair Value $ 2.81 $ 0.00 $ 2.81
Granted, Weighted-Average Grant Date Fair Value   1.73  
Vested, Weighted-Average Grant Date Fair Value   2.73 $ 7.83
Forfeited, Weighted-Average Grant Date Fair Value   $ 3.61  
Aggregate fair value of SARs vested   $ 5,400 $ 1,700
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period   0 years  
Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock or Unit Option Plan Expense   $ 254 $ 98
Stock Appreciation Rights (SARs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]      
Exercised, Shares   (1,002,652)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Nonvested at beginning of the year, Shares   1,255,565  
Granted, Shares   24,575  
Vested, Shares   (1,002,652)  
Forfeited, Shares   (277,488)  
Nonvested at end of the year, Shares 1,255,565 0 1,255,565
Nonvested, Weighted-Average Grant Date Fair Value $ 1.72 $ 0.00 $ 1.72
Granted, Weighted-Average Grant Date Fair Value   0.53  
Vested, Weighted-Average Grant Date Fair Value   1.66 $ 2.27
Forfeited, Weighted-Average Grant Date Fair Value   $ 1.84  
Aggregate fair value of SARs vested   $ 1,700 $ 500
Stock Appreciation Rights (SARs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Granted, Weighted-Average Grant Date Fair Value   $ 0.53 $ 1.56
Chief Financial Officer [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock Issued During Period, Shares, Other 117,187    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Fair Value Assumptions, Expected Term 5 years    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 3 years